Intraneural Ultrasound-guided Sciatic Nerve Block Minimum Effective Volume and Electrophysiologic Effects

Gianluca Cappelleri, Andrea Luigi Ambrosoli, Marco Gemma, Valeria Libera Eva Cedrati, Federico Bizzarri, Giorgio Francesco Danelli

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Both extra- and intraneural sciatic injection resulted in significant axonal nerve damage. This study aimed to establish the minimum effective volume of intraneural ropivacaine 1% for complete sensory-motor sciatic nerve block in 90% of patients, and related electrophysiologic variations. Methods: Forty-seven consecutive American Society of Anesthesiologists physical status I-II patients received an ultrasound-guided popliteal intraneural nerve block following the up-and-down biased coin design. The starting volume was 15 ml. Baseline, 5-week, and 6-month electrophysiologic tests were performed. Amplitude, latency, and velocity were evaluated. A follow-up telephone call at 6 months was also performed. Results: The minimum effective volume of ropivacaine 1% in 90% of patients for complete sensory-motor sciatic nerve block resulted in 6.6 ml (95% CI, 6.4 to 6.7) with an onset time of 19 ± 12 min. Success rate was 98%. Baseline amplitude of action potential (mV) at ankle, fibula, malleolus, and popliteus were 8.4 ± 2.3, 7.1 ± 2.0, 15.4 ± 6.5, and 11.7 ± 5.1 respectively. They were significantly reduced at the fifth week (4.3 ± 2.1, 3.5 ± 1.8, 6.9 ± 3.7, and 5.2 ± 3.0) and at the sixth month (5.9 ± 2.3, 5.1 ± 2.1, 10.3 ± 4.0, and 7.5 ± 2.7) (P < 0.001 in all cases). Latency and velocity did not change from the baseline. No patient reported neurologic symptoms at 6-month follow-up. Conclusions: The intraneural ultrasound-guided popliteal local anesthetic injection significantly reduces the local anesthetic dose to achieve an effective sensory-motor block, decreasing the risk of systemic toxicity. Persistent electrophysiologic changes suggest possible axonal damage that will require further investigation.

Original languageEnglish
Pages (from-to)241-248
Number of pages8
JournalAnesthesiology
Volume129
Issue number2
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Nerve Block
Sciatic Nerve
Local Anesthetics
Numismatics
Fibula
Injections
Neurologic Manifestations
Telephone
Ankle
Action Potentials
ropivacaine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Intraneural Ultrasound-guided Sciatic Nerve Block Minimum Effective Volume and Electrophysiologic Effects. / Cappelleri, Gianluca; Ambrosoli, Andrea Luigi; Gemma, Marco; Cedrati, Valeria Libera Eva; Bizzarri, Federico; Danelli, Giorgio Francesco.

In: Anesthesiology, Vol. 129, No. 2, 01.08.2018, p. 241-248.

Research output: Contribution to journalArticle

Cappelleri, Gianluca ; Ambrosoli, Andrea Luigi ; Gemma, Marco ; Cedrati, Valeria Libera Eva ; Bizzarri, Federico ; Danelli, Giorgio Francesco. / Intraneural Ultrasound-guided Sciatic Nerve Block Minimum Effective Volume and Electrophysiologic Effects. In: Anesthesiology. 2018 ; Vol. 129, No. 2. pp. 241-248.
@article{610d354fa7b54b1a911e2aeefc5a1d0d,
title = "Intraneural Ultrasound-guided Sciatic Nerve Block Minimum Effective Volume and Electrophysiologic Effects",
abstract = "Background: Both extra- and intraneural sciatic injection resulted in significant axonal nerve damage. This study aimed to establish the minimum effective volume of intraneural ropivacaine 1{\%} for complete sensory-motor sciatic nerve block in 90{\%} of patients, and related electrophysiologic variations. Methods: Forty-seven consecutive American Society of Anesthesiologists physical status I-II patients received an ultrasound-guided popliteal intraneural nerve block following the up-and-down biased coin design. The starting volume was 15 ml. Baseline, 5-week, and 6-month electrophysiologic tests were performed. Amplitude, latency, and velocity were evaluated. A follow-up telephone call at 6 months was also performed. Results: The minimum effective volume of ropivacaine 1{\%} in 90{\%} of patients for complete sensory-motor sciatic nerve block resulted in 6.6 ml (95{\%} CI, 6.4 to 6.7) with an onset time of 19 ± 12 min. Success rate was 98{\%}. Baseline amplitude of action potential (mV) at ankle, fibula, malleolus, and popliteus were 8.4 ± 2.3, 7.1 ± 2.0, 15.4 ± 6.5, and 11.7 ± 5.1 respectively. They were significantly reduced at the fifth week (4.3 ± 2.1, 3.5 ± 1.8, 6.9 ± 3.7, and 5.2 ± 3.0) and at the sixth month (5.9 ± 2.3, 5.1 ± 2.1, 10.3 ± 4.0, and 7.5 ± 2.7) (P < 0.001 in all cases). Latency and velocity did not change from the baseline. No patient reported neurologic symptoms at 6-month follow-up. Conclusions: The intraneural ultrasound-guided popliteal local anesthetic injection significantly reduces the local anesthetic dose to achieve an effective sensory-motor block, decreasing the risk of systemic toxicity. Persistent electrophysiologic changes suggest possible axonal damage that will require further investigation.",
author = "Gianluca Cappelleri and Ambrosoli, {Andrea Luigi} and Marco Gemma and Cedrati, {Valeria Libera Eva} and Federico Bizzarri and Danelli, {Giorgio Francesco}",
year = "2018",
month = "8",
day = "1",
doi = "10.1097/ALN.0000000000002254",
language = "English",
volume = "129",
pages = "241--248",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Intraneural Ultrasound-guided Sciatic Nerve Block Minimum Effective Volume and Electrophysiologic Effects

AU - Cappelleri, Gianluca

AU - Ambrosoli, Andrea Luigi

AU - Gemma, Marco

AU - Cedrati, Valeria Libera Eva

AU - Bizzarri, Federico

AU - Danelli, Giorgio Francesco

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: Both extra- and intraneural sciatic injection resulted in significant axonal nerve damage. This study aimed to establish the minimum effective volume of intraneural ropivacaine 1% for complete sensory-motor sciatic nerve block in 90% of patients, and related electrophysiologic variations. Methods: Forty-seven consecutive American Society of Anesthesiologists physical status I-II patients received an ultrasound-guided popliteal intraneural nerve block following the up-and-down biased coin design. The starting volume was 15 ml. Baseline, 5-week, and 6-month electrophysiologic tests were performed. Amplitude, latency, and velocity were evaluated. A follow-up telephone call at 6 months was also performed. Results: The minimum effective volume of ropivacaine 1% in 90% of patients for complete sensory-motor sciatic nerve block resulted in 6.6 ml (95% CI, 6.4 to 6.7) with an onset time of 19 ± 12 min. Success rate was 98%. Baseline amplitude of action potential (mV) at ankle, fibula, malleolus, and popliteus were 8.4 ± 2.3, 7.1 ± 2.0, 15.4 ± 6.5, and 11.7 ± 5.1 respectively. They were significantly reduced at the fifth week (4.3 ± 2.1, 3.5 ± 1.8, 6.9 ± 3.7, and 5.2 ± 3.0) and at the sixth month (5.9 ± 2.3, 5.1 ± 2.1, 10.3 ± 4.0, and 7.5 ± 2.7) (P < 0.001 in all cases). Latency and velocity did not change from the baseline. No patient reported neurologic symptoms at 6-month follow-up. Conclusions: The intraneural ultrasound-guided popliteal local anesthetic injection significantly reduces the local anesthetic dose to achieve an effective sensory-motor block, decreasing the risk of systemic toxicity. Persistent electrophysiologic changes suggest possible axonal damage that will require further investigation.

AB - Background: Both extra- and intraneural sciatic injection resulted in significant axonal nerve damage. This study aimed to establish the minimum effective volume of intraneural ropivacaine 1% for complete sensory-motor sciatic nerve block in 90% of patients, and related electrophysiologic variations. Methods: Forty-seven consecutive American Society of Anesthesiologists physical status I-II patients received an ultrasound-guided popliteal intraneural nerve block following the up-and-down biased coin design. The starting volume was 15 ml. Baseline, 5-week, and 6-month electrophysiologic tests were performed. Amplitude, latency, and velocity were evaluated. A follow-up telephone call at 6 months was also performed. Results: The minimum effective volume of ropivacaine 1% in 90% of patients for complete sensory-motor sciatic nerve block resulted in 6.6 ml (95% CI, 6.4 to 6.7) with an onset time of 19 ± 12 min. Success rate was 98%. Baseline amplitude of action potential (mV) at ankle, fibula, malleolus, and popliteus were 8.4 ± 2.3, 7.1 ± 2.0, 15.4 ± 6.5, and 11.7 ± 5.1 respectively. They were significantly reduced at the fifth week (4.3 ± 2.1, 3.5 ± 1.8, 6.9 ± 3.7, and 5.2 ± 3.0) and at the sixth month (5.9 ± 2.3, 5.1 ± 2.1, 10.3 ± 4.0, and 7.5 ± 2.7) (P < 0.001 in all cases). Latency and velocity did not change from the baseline. No patient reported neurologic symptoms at 6-month follow-up. Conclusions: The intraneural ultrasound-guided popliteal local anesthetic injection significantly reduces the local anesthetic dose to achieve an effective sensory-motor block, decreasing the risk of systemic toxicity. Persistent electrophysiologic changes suggest possible axonal damage that will require further investigation.

UR - http://www.scopus.com/inward/record.url?scp=85050776725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050776725&partnerID=8YFLogxK

U2 - 10.1097/ALN.0000000000002254

DO - 10.1097/ALN.0000000000002254

M3 - Article

AN - SCOPUS:85050776725

VL - 129

SP - 241

EP - 248

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 2

ER -